An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro

American Journal of Physiology - Renal Physiology

Volumn 275, Issue 2 44-2, 1998, Pages

  Tomita, Naruya ^a   Horiuchi, Masatsugu ^a   Tomita, Sawako ^a   Gibbons, Gary H ^a   Kim, John Y S ^a   Baran, Dana ^b   Dzau, Victor J ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell cycle; Cell cycle regulatory genes; Cultured cells; Glomerular mesangium; Transcriptional regulatory elements

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLINE; OLIGONUCLEOTIDE; ONCOPROTEIN; PROTEIN KINASE; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS; MESANGIUM CELL; NONHUMAN; ONCOGENE C MYB; ONCOGENE C MYC; POINT MUTATION; PRIORITY JOURNAL; RAT;

EID: 0031846920     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.275.2.f278     Document Type: Article

References (37)

1. Bagchi, S., R. Weinmann, and P. Raychaudhuri. The retinoblastoma protein co-purifies with E2F-I, an E1A-regulated inhibitor of transcription factor E2F. Cell 65: 1063-1072, 1991.
2. Bennett, C. F., M. Y. Chiang, H. Chan, J. E. Shoemaker, and C. K. Mirabelli. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41: 1023-1033, 1992.
3. Bielinska, A., R. A. Shivdasani, L. Zhang, and G. J. Nabel. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science 250: 997-1000, 1990.
4. Bruce, A., B. A. Sullenger, H. F. Gallardo, G. E. Ungers, and E. Gilboa. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63: 601-608, 1990.
5. Burger, A. R., J. D. Schuetz, E. G. Schuetz, and P. S. Guzelian. Paradoxical transcriptional activation of rat liver cytochrome P-450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16 alpha-carbonitrile: analysis by transient transfection into primary monolayer cultures of adult rat hepatocytes. Proc. Natl. Acad. Sci. USA 89: 2145-2149, 1992.
6. Chellappan, S. P., S. Heibert, M. Mudryj, J. M. Horovitz, and J. R. Nevins. The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053-1061, 1991.
7. Chiang, M. Y., H. Chan, M. A. Zounes, S. M. Ferrier, W. F. Lima, and C. F. Bennett. Antisense oligonucleotides inhibit intracellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266: 18162-18171, 1991.
8. Chittenden, T., D. M. Livingston, and W. G. Kaelin. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65: 1073-1082, 1992.
9. Dalton, S. Cell cycle regulation of the human cdc2 gene. EMBO J. 11: 1797-1804, 1992.
10. Feigner, P. L., and G. M. Ringold. Cationic liposome-mediated transfection. Nature 337: 387-388, 1989.
11. Field, S. J., F.-Y. Tsai, F. Kuo, A. M. Zubiaga, W. G. Kaelin, D. M. Livingston, S. H. Orkin, and M. E. Greenberg. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561, 1996.
12. Floege, J., E. Eng, B. A. Young, and R. J. Johnson. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int. 39, Suppl: S47-S54, 1993.
13. Harper, P. A., J. M. Robinson, R. L. Hoover, T. C. Wright, and M. J. Karnovsky. Improved methods for culturing rat glomerular cells. Kidney Int. 26: 875-880, 1984.
14. Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. A cDNA encoding a RB-binding protein with properties of the transcription factor E2F. Cell 70: 337-350, 1992.
15. Hiebert, S. W., M. Lipp, and J. R. Nevins. E1A-dependent trans-activation of the human MYC prompter is mediated by the E2F factor. Proc. Natl. Acad. Sci. USA 86: 3594-3598, 1989.
16. Horiuchi, M., N. Nakamura, S. S. Tang, G. Barrett, and V. J. Dzau. Molecular mechanism of tissue-specific regulation of mouse renin gene expression by cAMP. J. Biol. Chem. 266: 16247-16254, 1991.
17. Horiuchi, M., R. E. Pratt, N. Nakamura, and V. J. Dzau. Distinct nuclear proteins competing for an overlapping sequence of cyclic adenosine monophosphate and negative regulatory elements regulate tissue-specific mouse renin gene expression. J. Clin. Invest. 92: 1805-1811, 1993.
18. Ishiyama, M., H. Tominaga, M. Shiga, K. Sasamoto, Y. Ohkura, and K. Ueno. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol. Pharm. Bull. 19: 1518-1520, 1996.
19. Itoh, H., R. E. Pratt, and V. J. Dzau. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J. Clin. Invest. 86: 1690-1697, 1990.
20. Kaelin, W. G., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, and E. K. Flemington. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70: 351-364, 1992.
21. Kashgarian, M., and R. B. Sterzel, The pathobiology of the mesangium. Kidney Int. 41: 524-529, 1992.
22. Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Kealin, and D. M. Livingston. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 161-172, 1994.
23. Morishita, R., G. H. Gibbons, M. Horiuchi, K. E. Ellison, M. Nakajima, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. USA 92: 5855-5859, 1995.
24. Nevins, J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424-429, 1992.
25. Norbury, C., and P. Nurse. Animal cell cycles and their control. Annu. Rev. Biochem. 61: 441-470, 1992.
26. Owens, G. K., and L. G. Thompson. Expression of smooth muscle specific isoactin in cultured smooth muscle cells: relationship between growth and cytodifferentiation. J. Biol. Chem. 102: 343-352, 1986.
27. Sala, A., and B. Calabretta. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc. Natl. Acad. Sci. USA 89: 10415-10419, 1992.
28. Slanky, J. E., Y. Li, W. G. Kaelin, and P. J. Farnham. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol. 13: 1610-1618, 1993.
29. Thalmeier, K., H. Synovzik, R. Mertz, E. L. Winnacker, and M. Lipp. Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev. 3: 527-536, 1989.
30. Tomita, N., J. Higaki, R. Morishita, K. Kato, H. Mikami, Y. Kaneda, and T. Ogihara. Direct in vivo gene introduction into rat kidney. Biochem. Biophys. Res. Commun. 186: 129-134, 1992.
31. Tomita, N., J. Kim, Gibbons, G. H., D. Baran, M. Ogborn, R. A. K. Stahl, S. Tomita, L. Zhang, Y. Kaneda, and V. J. Dzau. In vivo gene therapy of anti-Thy 1 nephritis using E2F decoy oligonucleotide. J. Am. Soc. Nephrol. 6: 887, 1995.
32. Venturelli, D., S. Travali, and B. Calabretta. Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase a expression. Proc. Natl. Acad. Sci. USA 87: 5963-5967, 1990.
33. Wagner, S., and M. R. Green. A transcriptional tryst. Nature 352: 189-190, 1991.
34. Watson, R. J., P. J. Dyson, and J. McMahon. Multiple c-myb transcript cap sites are variously utilized in cells of mouse haematopoietic origin. EMBO J. 6: 1643-1651, 1987.
35. Weintraub, S. J., C. A. Prater, and D. C. Dean. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259-261, 1992.
36. Yamada, T., M. Horiuchi, R. Morishita, L. Zhang, R. E. Pratt, and V. J. Dzau. In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer. J. Clin. Invest. 96: 1230-1237, 1995.
37. Yamaguchi, M., Y. Hayashi, F. Hirose, S. Matsuoka, K. Shiroki, and A. Matsunaga. Activation of the mouse proliferating cell nuclear antigen gene promoter by adenovirus type 12 E1A proteins. Jpn. J. Cancer Res. 83: 609-617, 1992.